See up to 3 months of TDOC. The 7-day demo opens the 1M and 3M ranges and puts TDOC on your watchlist.
Start 7-day demoLatest TDOC insider trades
About Teladoc Health, Inc. (TDOC)
The SEC lists Teladoc Health, Inc. under CIK 0001477449, in offices and clinics of doctors of medicine. It is grouped with Health Care companies on this site.
TDOC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 73,442 | $461K |
| Grant or award | 2 | 277,041 | |
| Option exercise | 36 | 297,526 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TDOC insider transactions (Form 4)
11164 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Joseph Ronald Catapano - Officer | Option exercise | Common Stock | 2,083 | - footnote F1 | - | |
| Joseph Ronald Catapano - Officer | Open-market sale | Common Stock | 655 footnote F2 | $5.65 | $4K | |
| Joseph Ronald Catapano - Officer | Option exercise | Restricted Stock Units | 2,083 | $0.00 | - | |
| ||||||
| Option exercise | Common Stock | 3,642 | - footnote F1 | - | ||
| Option exercise | Common Stock | 39,160 | - footnote F2 | - | ||
| Open-market sale | Common Stock | 17,805 footnote F3 | $6.10 | $109K | ||
| Option exercise | Performance Stock Units | 3,642 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 39,160 | $0.00 | - | ||
| ||||||
| Option exercise | Common Stock | 4,556 | - footnote F1 | - | ||
| Option exercise | Common Stock | 8,717 | - footnote F1 | - | ||
| Open-market sale | Common Stock | 6,200 footnote F2 | $6.30 | $39K | ||
| Option exercise | Restricted Stock Units | 4,556 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 8,717 | $0.00 | - | ||
| ||||||
| Adam C. Vandervoort - Officer | Option exercise | Common Stock | 5,350 | - footnote F1 | - | |
| Adam C. Vandervoort - Officer | Option exercise | Common Stock | 9,152 | - footnote F1 | - | |
| Adam C. Vandervoort - Officer | Option exercise | Common Stock | 426 | - footnote F2 | - | |
| Adam C. Vandervoort - Officer | Open-market sale | Common Stock | 7,573 footnote F3 | $6.30 | $48K | |
| Adam C. Vandervoort - Officer | Option exercise | Restricted Stock Units | 5,350 | $0.00 | - | |
| Adam C. Vandervoort - Officer | Option exercise | Restricted Stock Units | 9,152 | $0.00 | - | |
| Adam C. Vandervoort - Officer | Option exercise | Performance Stock Units | 426 | $0.00 | - | |
| ||||||
| Option exercise | Common Stock | 4,859 | - footnote F1 | - | ||
| Option exercise | Common Stock | 9,152 | - footnote F1 | - | ||
| Option exercise | Common Stock | 1,300 | - footnote F2 | - | ||
| Open-market sale | Common Stock | 7,357 footnote F3 | $6.30 | $46K | ||
| Option exercise | Restricted Stock Units | 4,859 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 9,152 | $0.00 | - | ||
| Option exercise | Performance Stock Units | 1,300 | $0.00 | - | ||
| ||||||
| Joseph Ronald Catapano - Officer | Option exercise | Common Stock | 833 | - footnote F1 | - | |
| Joseph Ronald Catapano - Officer | Option exercise | Common Stock | 39 | - footnote F2 | - | |
| Joseph Ronald Catapano - Officer | Open-market sale | Common Stock | 274 footnote F3 | $6.30 | $2K | |
| Joseph Ronald Catapano - Officer | Option exercise | Restricted Stock Units | 833 | $0.00 | - | |
| Joseph Ronald Catapano - Officer | Option exercise | Performance Stock Units | 39 | $0.00 | - | |
| ||||||
| Option exercise | Common Stock | 42,277 | - footnote F1 | - | ||
| Option exercise | Common Stock | 1,966 | - footnote F2 | - | ||
| Open-market sale | Common Stock | 18,327 footnote F3 | $6.30 | $115K | ||
| Option exercise | Restricted Stock Units | 42,277 | $0.00 | - | ||
| Option exercise | Performance Stock Units | 1,966 | $0.00 | - | ||
| ||||||
| Option exercise | Common Stock | 5,492 | - footnote F1 | - | ||
| Option exercise | Common Stock | 1,042 | - footnote F1 | - | ||
| Option exercise | Common Stock | 8,717 | - footnote F1 | - | ||
| Open-market sale | Common Stock | 5,439 footnote F2 | $6.30 | $34K | ||
| Open-market sale | Common Stock | 9,812 | $6.51 | $64K | ||
| Option exercise | Restricted Stock Units | 5,492 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 1,042 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 8,717 | $0.00 | - | ||
| ||||||
| Michael F. Grasher - Officer | Grant or award | Restricted Stock Units | 239,616 | $0.00 | - | |
| Mark V. Anquillare - Director | Grant or award | Restricted Stock Units | 37,425 | $0.00 | - | |
| Open-market sale | Common Stock | 2,500 | $9.50 | $24K | ||
| Joseph Ronald Catapano - Officer | Option exercise | Common Stock | 2,083 | - footnote F1 | - | |
| Joseph Ronald Catapano - Officer | Open-market sale | Common Stock | 653 footnote F2 | $9.10 | $6K | |
| Joseph Ronald Catapano - Officer | Option exercise | Restricted Stock Units | 2,083 | $0.00 | - | |
| ||||||
| Open-market sale | Common Stock | 2,500 | $9.00 | $23K | ||
| Open-market sale | Common Stock | 2,500 | $8.50 | $21K | ||
| Option exercise | Common Stock | 39,160 | - footnote F2 | - | ||
| Open-market sale | Common Stock | 18,074 footnote F3 | $6.94 | $125K | ||
| Option exercise | Performance Stock Units | 3,642 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 39,160 | $0.00 | - | ||
| Option exercise | Common Stock | 3,642 | - footnote F1 | - | ||
| ||||||
| Open-market sale | Common Stock | 9,572 | $7.40 | $71K | ||
| Option exercise | Common Stock | 5,491 | - footnote F1 | - | ||
| Option exercise | Common Stock | 1,042 | - footnote F1 | - | ||
| Option exercise | Common Stock | 8,716 | - footnote F1 | - | ||
| Open-market sale | Common Stock | 5,677 footnote F2 | $7.63 | $43K | ||
| Option exercise | Restricted Stock Units | 5,491 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 1,042 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 8,716 | $0.00 | - | ||
| ||||||
| Adam C. Vandervoort - Officer | Option exercise | Common Stock | 426 | - footnote F1 | - | |
| Adam C. Vandervoort - Officer | Option exercise | Common Stock | 5,350 | - footnote F2 | - | |
| Adam C. Vandervoort - Officer | Option exercise | Common Stock | 9,152 | - footnote F2 | - | |
| Adam C. Vandervoort - Officer | Open-market sale | Common Stock | 7,906 footnote F3 | $7.63 | $60K | |
| Adam C. Vandervoort - Officer | Option exercise | Performance Stock Units | 426 | $0.00 | - | |
| Adam C. Vandervoort - Officer | Option exercise | Restricted Stock Units | 5,350 | $0.00 | - | |
| Adam C. Vandervoort - Officer | Option exercise | Restricted Stock Units | 9,152 | $0.00 | - | |
| ||||||
| Option exercise | Common Stock | 4,556 | - footnote F1 | - | ||
| Option exercise | Common Stock | 8,716 | - footnote F1 | - | ||
| Open-market sale | Common Stock | 6,196 footnote F2 | $7.63 | $47K | ||
| Option exercise | Restricted Stock Units | 4,556 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 8,716 | $0.00 | - | ||
| ||||||
| Option exercise | Common Stock | 1,966 | - footnote F1 | - | ||
| Option exercise | Common Stock | 42,276 | - footnote F2 | - | ||
| Open-market sale | Common Stock | 19,132 footnote F3 | $7.63 | $146K | ||
| Option exercise | Performance Stock Units | 1,966 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 42,276 | $0.00 | - | ||
| ||||||
| Joseph Ronald Catapano - Officer | Option exercise | Common Stock | 39 | - footnote F1 | - | |
| Joseph Ronald Catapano - Officer | Option exercise | Common Stock | 833 | - footnote F2 | - | |
| Joseph Ronald Catapano - Officer | Open-market sale | Common Stock | 284 footnote F3 | $7.63 | $2K | |
| Joseph Ronald Catapano - Officer | Option exercise | Performance Stock Units | 39 | $0.00 | - | |
| Joseph Ronald Catapano - Officer | Option exercise | Restricted Stock Units | 833 | $0.00 | - | |
| ||||||
| Option exercise | Common Stock | 1,300 | - footnote F1 | - | ||
| Option exercise | Common Stock | 4,858 | - footnote F2 | - | ||
| Option exercise | Common Stock | 9,152 | - footnote F2 | - | ||
| Open-market sale | Common Stock | 7,679 footnote F3 | $7.63 | $59K | ||
| Option exercise | Performance Stock Units | 1,300 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 4,858 | $0.00 | - | ||
| Option exercise | Restricted Stock Units | 9,152 | $0.00 | - | ||
| ||||||
| Mark Douglas Smith - Director | Grant or award | Restricted Stock Units | 30,441 | $0.00 | - | |
| Kenneth H. Paulus - Director | Grant or award | Restricted Stock Units | 30,441 | $0.00 | - | |
| Sandra L. Fenwick - Director | Grant or award | Restricted Stock Units | 30,441 | $0.00 | - | |
| David L. Shedlarz - Director | Option exercise | Common Stock | 29,986 | - footnote F1 | - | |
| David L. Shedlarz - Director | Option exercise | Restricted Stock Units | 28,986 | $0.00 | - | |
| David L. Shedlarz - Director | Grant or award | Restricted Stock Units | 30,441 | $0.00 | - | |
| ||||||
| Catherine Jacobson - Director | Option exercise | Common Stock | 28,986 | - footnote F1 | - | |
| Catherine Jacobson - Director | Option exercise | Restricted Stock Units | 28,986 | $0.00 | - | |
| Catherine Jacobson - Director | Grant or award | Restricted Stock Units | 30,441 | $0.00 | - | |
| ||||||
| David B. Snow Jr. - Director | Option exercise | Common Stock | 28,986 | - footnote F1 | - | |
| David B. Snow Jr. - Director | Option exercise | Restricted Stock Units | 28,986 | $0.00 | - | |
| David B. Snow Jr. - Director | Grant or award | Restricted Stock Units | 30,441 | $0.00 | - | |
| ||||||
| Joseph Ronald Catapano - Officer | Option exercise | Common Stock | 2,083 | - footnote F1 | - | |
| Joseph Ronald Catapano - Officer | Open-market sale | Common Stock | 675 footnote F2 | $5.11 | $3K | |
| Joseph Ronald Catapano - Officer | Option exercise | Restricted Stock Units | 2,083 | $0.00 | - | |
| ||||||
| Grant or award | Restricted Stock Units | 48,638 | $0.00 | - | ||
Recent TDOC Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| DIVITA CHARLES III | Officer, Director | 17,805 | $109K | View on EDGAR | |
| Rodrigues Fernando M. | Officer | 9,812 |
TDOC insider trading FAQ
What is the latest insider trade for TDOC?
Teladoc Health, Inc. (TDOC) had 10 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for TDOC runs to 64 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TDOC stock?
No insider purchases of TDOC were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling TDOC stock?
9 insider sales of TDOC were filed in the last 90 days, totaling $461K.
Where can I see TDOC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TDOC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joseph Ronald Catapano view on EDGAR
- - Charles Divita III view on EDGAR
- - Carlos Nueno view on EDGAR
- - Adam C. Vandervoort view on EDGAR
- - Kelly Bliss view on EDGAR
- - Joseph Ronald Catapano view on EDGAR
- - Charles Divita III view on EDGAR
- - Fernando M. Rodrigues view on EDGAR
- - Michael F. Grasher view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TDOC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TDOC with a 7-day demo
- TDOC on your watchlist
- Every TDOC Form 4 filing on record
- Up to 3 months of TDOC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive